These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3913752)

  • 1. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.
    De Benedittis G; Massei R
    J Neurosurg Sci; 1985; 29(3):239-48. PubMed ID: 3913752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of essential headache in developmental age with L-5-HTP (cross over double-blind study versus placebo)].
    Longo G; Rudoi I; Iannuccelli M; Strinati R; Panizon F
    Pediatr Med Chir; 1984; 6(2):241-5. PubMed ID: 6397729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.
    Ribeiro CA
    Headache; 2000 Jun; 40(6):451-6. PubMed ID: 10849040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.
    Caruso I; Sarzi Puttini P; Cazzola M; Azzolini V
    J Int Med Res; 1990; 18(3):201-9. PubMed ID: 2193835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxytryptophan: a clinically-effective serotonin precursor.
    Birdsall TC
    Altern Med Rev; 1998 Aug; 3(4):271-80. PubMed ID: 9727088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache in association with sleep disorders in children: a psychodiagnostic evaluation and controlled clinical study--L-5-HTP versus placebo.
    De Giorgis G; Miletto R; Iannuccelli M; Camuffo M; Scerni S
    Drugs Exp Clin Res; 1987; 13(7):425-33. PubMed ID: 3308389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study.
    Angst J; Woggon B; Schoepf J
    Arch Psychiatr Nervenkr (1970); 1977 Oct; 224(2):175-86. PubMed ID: 336002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan.
    Turner EH; Loftis JM; Blackwell AD
    Pharmacol Ther; 2006 Mar; 109(3):325-38. PubMed ID: 16023217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-5HTP treatment in primary headaches: an attempt at clinical identification of responsive patients.
    Bono G; Micieli G; Sances G; Calvani M; Nappi G
    Cephalalgia; 1984 Sep; 4(3):159-65. PubMed ID: 6388848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study.
    Keszthelyi D; Troost FJ; Jonkers DM; van Eijk HM; Dekker J; Buurman WA; Masclee AA
    Neurogastroenterol Motil; 2015 Aug; 27(8):1127-37. PubMed ID: 26031193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW; Mauskop A; Elkind AH; DeGryse R; Brin MF; Silberstein SD;
    Headache; 2005 Apr; 45(4):315-24. PubMed ID: 15836567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of 5-hydroxyindole compounds during L-5-HTP treatment in depressed patients.
    Takahashi S; Takahashi R; Masumura I; Miike A
    Folia Psychiatr Neurol Jpn; 1976; 30(4):461-73. PubMed ID: 1087913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.